HORIZANT (Gabapentin Enacarbil Extended-Release Tablets) for the Treatment of Alcohol Use Disorder

NCT02252536 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

346

Enrollment

NIH

Sponsor class

Conditions

Alcohol Use Disorder

Interventions

DRUG: gabapentin enacarbil
DRUG: Placebo

Sponsor

National Institute on Alcohol Abuse and Alcoholism (NIAAA)

Collaborators

[object Object]